Synthetic Lethal Therapy for KRAS Mutant Non-small-cell Lung Carcinoma with Nanoparticle-mediated CDK4 siRNA Delivery

The KRAS mutation is present in ~20% of lung cancers and has not yet been effectively targeted for therapy. This mutation is associated with a poor prognosis in non-small-cell lung carcinomas (NSCLCs) and confers resistance to standard anticancer treatment drugs, including epidermal growth factor re...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Mao, Cheng-Qiong, Xiong, Meng-Hua, Liu, Yang, Shen, Song, Du, Xiao-Jiao, Yang, Xian-Zhu, Dou, Shuang, Zhang, Pei-Zhuo, Wang, Jun
Format: Artigo
Sprog:Inglês
Udgivet: Nature Publishing Group 2014
Fag:
Original Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4015238/
https://ncbi.nlm.nih.gov/pubmed/24496383
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2014.18
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker